Once a postdoctoral fellow with Chad Mirkin here at Northwestern University, Jarad Mason now leads his own research group within the Department of Chemistry and Chemical Biology at Harvard University where his research includes investigating the potential of nanoparticle-loaded water to extend organ viability for transplantation. In this episode he discusses the balance between academia and industry in pushing scientific boundaries, as well as the future directions of his research in energy, sustainability, and biomedical applications.

In this episode, Northwestern University chemist Roel Templaar, PhD, gives a glimpse into the intricacies of quantum mechanics and its applications in nanotechnology. He explains how his work challenges classical theories, particularly in the field of chiral light-matter interactions.

In this episode, Northwestern Medicine neuro-oncologist, Priya Kumthekar, MD, discusses her pioneering work in nanomedicine on an early clinical trial in individuals with the deadly brain cancer glioblastoma. The study showed an experimental spherical nucleic acid drug, developed by Northwestern University scientists, was able to penetrate the blood-brain barrier and trigger the death of tumor cells. This was the first time a nanotherapeutic has been shown to cross the blood-brain barrier. The study set a precedent at Northwestern University and has opened the door for similar studies and innovations to take place here.